NCT06799650View on ClinicalTrials.gov

Clinical Trial of Gammora® Plus Antiretroviral Treatment for HIV

PHASE2RecruitingINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

September 15, 2025

Study Completion Date

November 1, 2025

Conditions

HIV Seropositivity

Interventions

DRUG

Gammora®

Gammora® SC + Tenofovir/3TC + darunavir+ritonavir

Trial Locations (1)

04039-032

RECRUITING

RDSS, São Paulo

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Code Pharma

INDUSTRY

lead

Federal University of São Paulo

OTHER